Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
Not yet recruiting · NCT07187466 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, overactive bladder, parkinsonian disorder, synucleinopathy, urinary bladder disorder, urinary system disorder | Not yet recruiting | Phase 4 | 2026-07-22 | NCT07187466 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| VA Office of Research and Development | 472 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atlanta VA Medical and Rehab Center, Decatur, GA | Decatur | United States | 34 |
| Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA | Philadelphia | United States | 25 |
| VA Salt Lake City Health Care System, Salt Lake City, UT | Salt Lake City | United States | 24 |